there were no significant differences between the hyaluronidase- and placebo-treated patients in incidence of ami ( 86 vs 88 % ) , creatine kinase-mb infarct size index ( 14.6 +/- 0.8 vs 15.1 +/- 0.7 ck-mb-geq/m2 ) , change in total r wave from time 0 to 72 hours for anterior transmural ischemia or infarction ( -34 +/- 7 vs -35 +/- 8 mv ) , infarct size determined by pyrophosphate scintigrams ( 27 +/- 1 vs 27 +/- 1 cm2 ) , change in left ventricular ejection fraction from day 0 to day 10 ( + 2.4 +/- 0.7 vs + 1.2 +/- 0.7 % ) or cumulative proportion surviving 4 years ( 0.70 +/- 0.03 vs 0.68 +/- 0.03 ) .
C0022116
ischemia
C0021308
infarct